Clinical Trials Logo

Frailty clinical trials

View clinical trials related to Frailty.

Filter by:

NCT ID: NCT06100445 Recruiting - Health Behavior Clinical Trials

Exercise Engagement in People Over 60 at Risk of Falls

Start date: January 26, 2024
Phase:
Study type: Observational

It is a qualitative study, using semi structured interviews to explore patient's experiences of falls and their perceptions on facilitators and barriers to exercise. Aim: To explore reasons for and against engaging with exercises at home in participants over the age of 60 at risk of falls. To explore: 1. Patients' preferences to exercise format and type eg/ leaflet, online, access, such as the Chartered Society of Physiotherapy (CSP) chair exercises leaflet or individual personalized rehabilitation programme handouts 2. The ability to discuss falls risk with health professionals. 3. If health inequalities exist with people at risk of falls and exercising. 4. Sustainability of exercise, in order to reduce the risk of falls in this population. 5. The need to develop MSK internal and external facing falls management pathways. Suitability: Patients over the age of 60, who have been identified at risk of falls, having been referred to MSK Physiotherapy in Rossendale. 'Risk of falls' is defined as: patient self-reports they are unsteady, had one or more fall in the last 6 months, or clinician identified a slow/unsteady gait pattern on examination. Semi structured interviews on up to ten participants. It is anticipated that this sample size will give adequate data saturation. Approximately 12 months from participant recruitment to analysis of findings.

NCT ID: NCT06099912 Not yet recruiting - Multiple Myeloma Clinical Trials

Dynamic Frailty Assessment for Guiding the Treatment in Older Adults With Newly Diagnosed Multiple Myeloma

DFA
Start date: July 1, 2024
Phase:
Study type: Observational

Investigators designed the single-center, prospective real-world based clinical study with the aim of applying the standardized geriatric assessment system IMWG-FS internationally for dynamic frailty assessment of elderly newly diagnosed multiple myeloma(NDMM), guiding therapeutic decision based on their fit/frail status (fit → intensive; frail → mild), to observe their treatment tolerance, treatment related adverse events(TRAE), treatment discontinued(TD), and survival(progression survivaland overall survival).

NCT ID: NCT06099691 Completed - Frailty Clinical Trials

Outcomes That Matter and Questionnaires for Older People With Frailty

Start date: December 18, 2023
Phase:
Study type: Observational

The goal of this qualitative study is to investigate what matters to older people living with frailty, and how this can be measured using questionnaires (Patient Reported Outcome Measures, or "PROMs"). The research questions are: 1. What outcomes matter to older adults living with frailty? 2. What are participants' perceptions of PROMs that could measure these outcomes? Our estimated sample will be 15 older adults, approximately 5 people living with mild frailty, 5 living with moderate frailty and 5 living with severe frailty. Participants will take part in one 90-minute interview.

NCT ID: NCT06096922 Recruiting - Frailty Clinical Trials

AI-based Frailty Assessment Tool for Patients Undergoing Cardiac Surgery

Start date: November 1, 2023
Phase:
Study type: Observational

The main purpose of this study is to establish a frailty automatic evaluation index "AI frailty index" based on artificial intelligence multi-modal non-contact monitoring information analysis. At the same time, the study will explore the correlation between ' AI weakness index ' and perioperative and long-term prognosis and quality of life.

NCT ID: NCT06094582 Recruiting - Aging Clinical Trials

Knowledges and Use of Cannabidiol in Older Adults

CBD-65
Start date: October 26, 2023
Phase:
Study type: Observational

The use of non-medical cannabidiol (CBD) has been growing recently in France and in the world, in young but also older adults. Few data are available on the use of cannabidiol in older adults. A better knowledge of the use of cannabidiol in older adults, and of their own knowledges of the molecule, is necessary to guide and follow the CBD uptake in this population and avoid potential adverse events.

NCT ID: NCT06089473 Not yet recruiting - Frailty Clinical Trials

Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The goal of this RCT is to address the feasibility of conducting a 12-week virtual pre-habilitation intervention, which includes exercise and education, in kidney transplant candidates. The intervention also includes a 5-month maintenance phase with independent home exercises (maximum of 8 months of intervention/ended early if the participant undergoes a kidney transplant). The main questions it aims to answer are: - estimate the proportion of screened patients who meet eligibility criteria - estimate the proportion of eligible patients who consent to randomization - estimate the proportion of patients who adhere to the interventions - estimate follow-up completion rates - inform the calculation of sample size requirements for a full-scale RCT - assess the acceptability of the intervention by the participants. Participants in the control group will receive usual outpatient care.

NCT ID: NCT06089083 Recruiting - Gynecologic Cancer Clinical Trials

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

PROOF
Start date: October 18, 2023
Phase:
Study type: Observational

This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.

NCT ID: NCT06079762 Active, not recruiting - Aging Clinical Trials

AGE SELF CARE: Promoting Healthy Aging Through a Group Visit Program

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Aim 1: To assess the feasibility and acceptability of delivering AGE SELF CARE through virtual medical group visits by measuring recruitment rate, adherence, and participant satisfaction. Hypothesis 1: It will be feasible to recruit 12 older adults who are pre-frail. Hypothesis 2: At least 70% of participants will attend 6 of 8 group visit sessions. Hypothesis 3: At least 70% of participants will report satisfaction with the program. Aim 2: Determine the feasibility and burden of measuring frailty in this study by different instruments. Hypothesis 1: At least 70% of participants will complete portions of all frailty assessments. Hypothesis 2: Participants will not find testing to be burdensome and measures may be completed in 60 minutes or less. Hypothesis 3: Mean gait speed and frailty index will improve from baseline to post-intervention.

NCT ID: NCT06073106 Not yet recruiting - Breast Cancer Clinical Trials

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

OPTIMA-C
Start date: December 2023
Phase:
Study type: Observational

The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty. In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.

NCT ID: NCT06071611 Completed - Cognitive Frailty Clinical Trials

Cognitive Frailty and Oxygen-ozone Therapy

Start date: July 2, 2019
Phase: N/A
Study type: Interventional

As the world's population age, frailty is moving to the forefront of health and medical research and may become one of the world's most serious health issues. Understanding frailty prevention and treatment becomes even more crucial in order to reduce national healthcare costs. Oxygen-Ozone (O2-O3) therapy is a no-invasive/no-pharmacological and low cost procedure based on the therapeutic effects of low O3 concentrations, already used in medicine as an alternative/adjuvant treatment for different diseases and in the elderly. This project is the first pilot double blind randomized controlled trial where a group of elderly frail subjects are stratified as untreated (air), treated with pure O2 and treated with a mixture of O2-O3. The biological corollary will be transcriptomics, proteomics and also cognitive impairment assessment at baseline and after treatment. An algorithm combining these data will identify biomarkers of the response to O2-O3 therapy.